NCT02313922View on ClinicalTrials.gov

Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate

PHASE4CompletedINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Psoriasis
Interventions
DRUG

etanercept combined with methotrexate or etanercept combined with placebo

Trial Locations (1)

310009

the 2Nd Affiliated Hospital,Zhejiang University,, Hangzhou

All Listed Sponsors
collaborator

Shanghai CP Guojian Pharmaceutical Co., Ltd.

INDUSTRY

lead

Zhejiang University

OTHER

NCT02313922 - Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate | Biotech Hunter | Biotech Hunter